Reuters Health Report: August 25, 2017

Click to View in Browser Friday, August 25, 2017 Samsung, Biogen version of AbbVie's Humira approved in Europe (Reuters) - A biosimilar version of AbbVie Inc's blockbuster arthritis drug Humira, produced by a joint venture of Biogen Inc and Samsung Biologics, was approved by European Union regulators, the partners said on Thursday. China says will check egg producers for use of fipronil insecticide BEIJING (Reuters) - Chinese authorities said on Friday they will launch spot checks of egg producers to make sure a toxic chemical known as fipronil is not being used as a cleaning product, in animal drugs or feed after higher than acceptable levels of the insecticide were detected in farms in Europe. Last 'bare county' in U.S. to get health insurer next year NEW YORK (Reuters) - Ohio's Department of Insurance said on Thursday that non-profit managed care company CareSource will sell health plans in Paulding County next year - the last county in the United States that would have been without Obamacare individual coverage in 2018. Adamas Pharma secures approval for Parkinson's dyskinesia drug (Reuters) - The U.S. Food and Drug Administration (FDA) said it had approved Adamas Pharmaceuticals Inc's treatment for a side effect caused by a commonly prescribed Parkinson's drug, sending the shares of the drugmaker soaring in after-market trading. Philippines watching suspected bird flu cases in humans MANILA (Reuters) - The Philippines started monitoring suspected bird flu cases in humans on Friday after 34 farm workers in two towns north of the capital Manila developed flu-like symptoms after direct exposure to infected fowl. Primary care access tied to fewer sexually transmitted infections (Reuters Health) - For women, greater access to primary care providers may be linked to a lower risk of sexually transmitted infections (STIs), a U.S. study suggests. Elders may face hearing challenges at doctor's offices (Reuters Health) - Many older adults may mishear important medical information from their healthcare providers, a study suggests. Roche says FDA grants priority review to hemophilia drug emicizumab ZURICH (Reuters) - Swiss pharma group Roche said the U.S. Food and Drug Administration (FDA) granted priority review to its emicizumab for hemophilia A with inhibitors. Novartis receives EU approval for breast cancer drug Kisqali ZURICH (Reuters) - Novartis AG said its drug Kisqali (ribociclib) received European Union approval as first-line treatment for a tough-to-treat breast cancer, bolstering the Swiss drugmaker's bid to challenge U.S. rival Pfizer's Ibrance. Surgery survival for elderly tied to frailty and cognitive skills Reuters Health - Taking both physical frailty and cognitive impairment into account may yield a better estimate than either factor alone of the odds an older person will survive after major surgery, a U.S. study suggests. Related Video Students design solar-powered car to help Egypt's disabled In Montana's Indian country, tribes take opposite sides on coal A quick-fix on the day's news delivered when you want it. Register Today A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today » » MORE NEWSLETTERS - 3 Times Square New York, NY 10036 USA © Copyright 2017 Thomson Reuters Ensure delivery of Reuters Newsmails, add newsletters@email.reuters.com to your address book. Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook